Dysthyroid Orbitopathy Presenting with Gaze-Evoked Amaurosis: Case Report and Review of the Literature
暂无分享,去创建一个
[1] E. Bradley,et al. Randomized controlled trial of rituximab in patients with Graves' orbitopathy. , 2015, The Journal of clinical endocrinology and metabolism.
[2] P. Perros,et al. The effect of B cell depletion therapy on anti‐TSH receptor antibodies and clinical outcome in glucocorticoid‐refractory Graves' orbitopathy , 2013, Clinical endocrinology.
[3] Terry J. Smith,et al. Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy. , 2010, Ophthalmology.
[4] J. Garrity,et al. Amaurosis and optic disc blanching during upgaze in graves ophthalmopathy. , 2009, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[5] J. Romijn,et al. Rituximab in relapsing Graves' disease, a phase II study. , 2008, European journal of endocrinology.
[6] R. Mazzoli,et al. Gaze-evoked amaurosis: a report of five cases. , 2003, Ophthalmology.
[7] M. Sanders,et al. Gaze evoked amaurosis in dysthyroid orbitopathy , 1999, The British journal of ophthalmology.
[8] W. Mcdonald,et al. Transient uniocular visual loss on deviation of the eye in association with intraorbital tumours. , 1987, Journal of neurology, neurosurgery, and psychiatry.
[9] G. Krohel,et al. Gaze-evoked blindness. , 1983, Annals of ophthalmology.